Koers Hypertension Diagnostics, Inc. Other OTC
Aandelen
HDII
US44914V1044
Geavanceerde medische apparatuur & technologie
Omzet 2017 | 3,68 mln. 3,43 mln. | Omzet 2018 | 3,79 mln. 3,54 mln. | Marktkapitalisatie | 92,08K 85,9K |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 | Nettowinst (verlies) 2018 | - 0 | EV/omzet 2017 | 1,15 x |
Nettoschuld 2017 | 4,13 mln. 3,86 mln. | Nettoschuld 2018 | 4,6 mln. 4,29 mln. | EV/omzet 2018 | 1,24 x |
K/w-verhouding 2017 |
-0,28
x | K/w-verhouding 2018 |
-0,54
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,33% | 219 mld. | |
+6,72% | 183 mld. | |
+10,18% | 132 mld. | |
+24,91% | 106 mld. | |
-0,95% | 62,09 mld. | |
+10,56% | 50,8 mld. | |
+4,81% | 50,88 mld. | |
-0,24% | 40,64 mld. | |
+1,22% | 35,71 mld. |